Tandem t:slim X2 Insulin Pump app defect may cause therapy errors
The Tandem t:slim X2 insulin pump app may fail to communicate properly on right-to-left language phones, potentially causing incorrect insulin doses and blood sugar problems.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with no reported injuries or illnesses. However, the app defect affects critical insulin delivery communications, and the source identifies potential for incorrect therapy decisions leading to blood sugar abnormalities—a risk-of-harm product scenario per the severity rubric.
Plain-English summary
The FDA is recalling 19 Tandem t:slim X2 Insulin Pumps distributed to Israel due to a software defect in the mobile app.
The defect occurs when a user's phone is configured with a right-to-left language setting. This causes the app to malfunction in communicating with the insulin pump, including pairing failures and display errors. The app-pump communication failures can lead to incorrect therapy decisions and potential blood sugar abnormalities including hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar).
Users with affected devices should contact Tandem Diabetes Care immediately for guidance. Patients should not ignore any unusual pump or app behavior and should monitor blood sugar levels closely. If experiencing symptoms of low or high blood sugar, seek immediate medical attention.
The recalled product
- Product
- t:slim X2 Insulin Pump with Interoperable Technology (with Tandem t:slim mobile app)
- Manufacturer
- Tandem Diabetes Care, Inc.
- Hazard
- app-malfunction
- device-pairing-failure
- insulin-dosing-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Tandem t:slim Mobile App
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- HighGE CARESCAPE Telemetry Server may lose patient ECG and oxygen saturation monitoring
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03
- SevereMedline Spinal Trays Recalled Due to Quality and Efficacy Concerns
FDA (Devices) · 2026-06-03
- HighPhilips Azurion and Allura Imaging Systems Recalled for Hard Drive Degradation
FDA (Devices) · 2026-06-03
- HighPhilips Allura Imaging Systems Hard Drive Degradation Affects Functionality
FDA (Devices) · 2026-06-03